Furthermore, the improved group was not fully remitted, with 17 individuals still meeting PTSD diagnostic criteria at follow-up, which may have obscured potential differences
Reduces melanin production to promote even-toned skin while enhancing radiance for a glowing and healthy complexion
Jain A, Pooladanda V, Bulbake U, Doppalapudi S, Rafeeqi TA, Godugu C, et al
Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence